{
    "title": "104_hr1496",
    "content": "The Act titled \"Prostate Cancer Diagnosis and Treatment Act of 1995\" allows Medicare coverage for prostate cancer screening and certain drug treatments. The \"Prostate Cancer Diagnosis and Treatment Act of 1995\" enables Medicare coverage for prostate cancer screening services for early detection. \"Services for early detection of prostate cancer are covered by Medicare under the Prostate Cancer Diagnosis and Treatment Act of 1995.\" The Prostate Cancer Diagnosis and Treatment Act of 1995 covers services for the early detection of prostate cancer, including digital rectal examination, prostate-specific antigen blood test, transrectal ultrasonography, and other designated procedures. Payment amounts and frequency limits for these services are specified in the Act. Payment for services for early detection of prostate cancer is limited to the frequency allowed and is 80% of the actual charge or the fee schedule amount for specific tests. Payment for early detection of prostate cancer services is limited to specific tests and frequencies, with coverage subject to age restrictions and deductible requirements. Payment for early detection of prostate cancer services is limited to specific tests and frequencies, with coverage subject to age restrictions and deductible requirements. Payment may be made for services provided within 11 months after a previous service, with exceptions for high-risk individuals determined by the Secretary. The Secretary, in consultation with the Director of the National Cancer Institute, periodically reviews the guidelines for early detection services. The Secretary, in consultation with the National Cancer Institute, periodically reviews the appropriate frequency for early detection of prostate cancer services based on age and other relevant factors. The Secretary may revise the frequency of services paid for under this subsection, with no changes applying before January 1, 1998. The Secretary also establishes fee schedules for these services. The Secretary establishes fee schedules for early detection of prostate cancer services, considering variations in costs among geographic areas and sites. Payment amounts are to be equitable. The Secretary establishes fee schedules for early detection of prostate cancer services to ensure equitable payment amounts. Nonparticipating physicians providing services to enrolled individuals are subject to limitations on charges. Conforming amendments are made to certain sections of the Act. Amendments are made to sections 1833(a)(1) and 1833(a) of the Act regarding payment amounts for early detection of prostate cancer services. Nonparticipating physicians are limited in their charges for services provided to enrolled individuals. Amendments are made to sections 1833(a)(1) and 1833(a) of the Act regarding payment amounts for early detection of prostate cancer services. Nonparticipating physicians are limited in their charges for services provided to enrolled individuals. Additionally, changes are made to sections 1833(h)(1)(A) and 1862(a) of the Act. Amendments are made to sections 1833(a)(1) and 1833(a) of the Act regarding payment amounts for early detection of prostate cancer services. Nonparticipating physicians are limited in their charges for services provided to enrolled individuals. Additionally, changes are made to section 1861(s)(2) of the Social Security Act for coverage of certain drug treatments. Amendments made to sections 1833(a)(1) and 1833(a) of the Act regarding payment amounts for early detection of prostate cancer services. Effective date for services provided on or after January 1, 1996, without regard to fee schedules established by the Secretary. SEC. 3. Early detection and treatment of prostate cancer in veterans. The text discusses amending the United States Code to include tests for early detection and diagnosis of prostate cancer, as well as coverage for services related to prostate cancer detection and treatment for veterans. The Secretary shall implement a schedule for early detection of prostate cancer for veterans confined to hospitals or other institutions, including procedures like digital rectal examinations, PSA blood tests, and transrectal ultrasonography. Treatment services may include FDA-approved drugs. The Secretary is also authorized to conduct research and research training in this area. The Secretary may conduct research on diagnosis and treatment of prostate cancer and develop treatment guidelines. A clerical amendment is made to the table of sections in the chapter. Research and education on prostate cancer, including detection and treatment, are addressed in this section of the document. The Secretary is authorized to conduct research and develop treatment guidelines for prostate cancer. The Public Health Service Act is amended to increase funding for the National Institutes of Health and the Agency for Health Care Policy and Research, specifically for activities related to prostate cancer research and health services. The Public Health Service Act is amended to increase funding for the National Institutes of Health and the Agency for Health Care Policy and Research, specifically for activities related to prostate cancer research and health services. This includes the development, periodic review, and updating of clinically relevant guidelines, standards of quality, performance measures, and medical review criteria."
}